C.B. Fleet Acquired by Prestige Brands
TM Capital served as a financial advisor to C.B. Fleet Company, Inc. in its $825 million sale to Prestige Brands
TM Capital served as a financial advisor to C.B. Fleet Company, Inc. in its $825 million sale to Prestige Brands
TM Capital, together with Pegasus Capital, served as a financial advisor to Empirical Bioscience in its sale to Fortis Life Sciences
TM Capital rendered a fairness opinion to the Board of Directors of BioLok International Inc. (OTC) with respect to the sale of BioLok to Healthpoint Capital